OAK BROOK, Ill. — Retractable Technologies earlier this month won the Drug Store News/ECRM Buyers’ Choice Award for its VanishPoint syringes, blood collection products, and IV catheters during the recent ECRM Diabetes/Clinical Programs, Chronic Care Management & Adherence Solutions EPPS, held here.
The finalist was Smart Meter for its iGlucose Diabetes Solution.
The two companies were selected from dozens of entries in the award program, samples of which were displayed in the ECRM hospitality area during the EPPS meetings. Buyers cast their votes based on product innovation and packaging. The session featured products, patient services and retailer programs targeting the diabetic or other chronically managed patients.
Retractable Technologies manufactures safety medical devices. Its VanishPoint syringes, blood collection products and IV catheters feature pre-removal activation, effectively reducing the risk of needlestick injuries and preventing reuse. The EasyPoint retractable needle is compatible with both luer lock and luer slip syringes (3 mL or smaller) and can be used with pre-filled syringes.
The company also makes Patient Safe syringes, which are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination.
Smart Meter is a global diabetes management technology that enables the proactive management of diabetes by way of a cell-enabled solution that uploads real-time glucose readings to people with diabetes and their circle of care. It includes a cell-enabled blood glucose meter, an automated virtual care coach and web-based patient and population management portals, and was developed to eliminate syncing or paring complications when trying to share blood glucose test results.